Testarea anuală a testosteronului în armata SUA, criticată de experți

The Pentagon's new annual testosterone testing policy for U.S. military personnel raises concerns among medical experts about potential over-prescription of hormone therapy. While aimed at enhancing combat readiness, specialists warn of significant side effects, including infertility and increased risk of blood clots. Starting July 15, all active and reserve military members over 30 will undergo testing, which experts believe exceeds current medical guidelines. They emphasize that isolated low testosterone results are insufficient for diagnosis or treatment initiation. The Defense Secretary argues the measure is intended to optimize physical performance and long-term health.